US5962030A
(en)
|
1997-03-07 |
1999-10-05 |
Akesis Pharmaceuticals, Inc. |
Dietary supplement and method of treatment for diabetic control
|
GB9715444D0
(en)
*
|
1997-07-22 |
1997-09-24 |
Scotia Holdings Plc |
Therapeutic and dietary compositions
|
IT1302125B1
(it)
*
|
1998-08-03 |
2000-07-31 |
Sigma Tau Healthscience Spa |
Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide
|
IT1302307B1
(it)
|
1998-09-01 |
2000-09-05 |
Sigma Tau Healthscience Spa |
Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
|
US6376549B1
(en)
|
1998-09-17 |
2002-04-23 |
Akesis Pharmaceuticals, Inc. |
Metforimin-containing compositions for the treatment of diabetes
|
CA2344246A1
(en)
|
1998-09-17 |
2000-03-23 |
Akesis Pharmaceuticals, Inc. |
Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
|
IT1302365B1
(it)
*
|
1998-10-09 |
2000-09-05 |
Sigma Tau Healthscience Spa |
Uso di carnitine e resveratrolo per produrre una composizione per laprevenzione o il trattamento terapeutico di alterazioni cerebrali
|
IT1306130B1
(it)
*
|
1999-04-16 |
2001-05-30 |
Sigma Tau Healthscience Spa |
Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.
|
IT1306133B1
(it)
*
|
1999-04-22 |
2001-05-30 |
Sigma Tau Healthscience Spa |
Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
|
IT1306179B1
(it)
*
|
1999-07-28 |
2001-05-30 |
Sigma Tau Healthscience Spa |
Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
|
NZ517597A
(en)
*
|
1999-09-03 |
2003-11-28 |
Sigma Tau Healthscience S |
L-carnitine with a particle size that can pass through a 100 USBS mesh sieve, methods of preparing the same, compositions containing the same, and methods of using the same
|
IT1316997B1
(it)
*
|
2000-03-02 |
2003-05-26 |
Sigma Tau Healthscience Spa |
Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
|
IT1316998B1
(it)
*
|
2000-03-02 |
2003-05-26 |
Sigma Tau Healthscience Spa |
Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
|
EP1305018A4
(en)
*
|
2000-08-02 |
2006-08-30 |
Pharmanutrients |
METHODS AND COMPOUNDS FOR PROPHYLAXIS AND / OR TREATMENT OF DIABETES AND GLUCOSE DEREGULATION
|
US8669282B2
(en)
|
2000-10-31 |
2014-03-11 |
Hill's Pet Nutrition, Inc. |
Companion animal compositions including lipoic acid and methods of use thereof
|
US20020076470A1
(en)
|
2000-10-31 |
2002-06-20 |
Colgate-Palmolive Company |
Composition and method
|
US20020098247A1
(en)
*
|
2000-11-02 |
2002-07-25 |
Komorowski James R. |
Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid
|
US20020155170A1
(en)
|
2000-11-30 |
2002-10-24 |
Walsh William John |
Nutrient supplements and methods for treating autism and for preventing the onset of autism
|
US6555573B2
(en)
|
2000-12-21 |
2003-04-29 |
The Quigley Corporation |
Method and composition for the topical treatment of diabetic neuropathy
|
US20040043013A1
(en)
|
2000-12-28 |
2004-03-04 |
Mccleary Edward Larry |
Metabolic uncoupling therapy
|
US20060062864A1
(en)
*
|
2000-12-28 |
2006-03-23 |
Mccleary Edward L |
Weight loss composition and method
|
ITBS20010027A1
(it)
*
|
2001-03-23 |
2002-09-23 |
Gen Topics Srl |
Principio attivo a base di acido lipoico ed acidi grassi polienolici
|
US20060014773A1
(en)
*
|
2001-04-19 |
2006-01-19 |
Mccleary Edward L |
Mental agility lozenge, edible strip, food or drink
|
US6964969B2
(en)
|
2001-04-19 |
2005-11-15 |
Mccleary Edward Larry |
Composition and method for treating impaired or deteriorating neurological function
|
JP2002348244A
(ja)
*
|
2001-05-23 |
2002-12-04 |
Fancl Corp |
抗糖尿病組成物
|
NZ533439A
(en)
*
|
2001-12-19 |
2006-06-30 |
The Quigley Corp |
Methods for the treatment of peripheral neural and vascular ailments using flavonoid compositions
|
ITMI20012732A1
(it)
*
|
2001-12-20 |
2003-06-20 |
Health Pharma S R L |
Integratore alimentare per neuropatici
|
TW200304372A
(en)
*
|
2002-03-20 |
2003-10-01 |
Kanegafuchi Chemical Ind |
Compositions for diabetes
|
WO2003079819A1
(en)
*
|
2002-03-27 |
2003-10-02 |
Anglo French Drugs And Industries Ltd. |
Dietary supplement composition and a process of manufacturing said composition
|
US6974592B2
(en)
*
|
2002-04-11 |
2005-12-13 |
Ocean Nutrition Canada Limited |
Encapsulated agglomeration of microcapsules and method for the preparation thereof
|
US7977049B2
(en)
*
|
2002-08-09 |
2011-07-12 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
SE526943C2
(sv)
*
|
2002-08-26 |
2005-11-22 |
Indevex Ab |
Födoämneskompositionsprodukt
|
DK1575561T3
(da)
*
|
2002-11-04 |
2010-09-20 |
Ocean Nutrition Canada Ltd |
Mikrokapsel med flere kapper og fremgangsmåde til fremstilling heraf
|
US7083813B2
(en)
|
2002-11-06 |
2006-08-01 |
The Quigley Corporation |
Methods for the treatment of peripheral neural and vascular ailments
|
US7776913B2
(en)
|
2002-12-13 |
2010-08-17 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Carnitines for treating or preventing disorders caused by andropause
|
AU2004253579B2
(en)
*
|
2003-07-01 |
2010-12-23 |
Biomol International L.P. |
Sirt1 modulators for manipulating cells/organism lifespan/stress response
|
US20060025337A1
(en)
*
|
2003-07-01 |
2006-02-02 |
President And Fellows Of Harvard College |
Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
|
CA2436650A1
(en)
*
|
2003-08-06 |
2005-02-06 |
Naturia Inc. |
Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
|
US20050202063A1
(en)
*
|
2003-08-26 |
2005-09-15 |
Ebn International Kft |
Food product
|
US7875291B1
(en)
|
2003-09-05 |
2011-01-25 |
Glu-Pro, Inc. |
Composition for managing diabetes, obesity, and hyperlipidemia and associated methods
|
EP1537896B1
(de)
*
|
2003-12-03 |
2008-04-02 |
Franz-Peter Dr. Liebel |
Stoffgemische basierend auf schwefelhaltigen Aminosäuren, Antioxidantien, Phospholipiden und Vitaminen zur Herstellung eines Arzneimittels für die Behandlung des L-Diabetes und/oder assoziierter Erkrankungen
|
US8017634B2
(en)
|
2003-12-29 |
2011-09-13 |
President And Fellows Of Harvard College |
Compositions for treating obesity and insulin resistance disorders
|
US20050171027A1
(en)
*
|
2003-12-29 |
2005-08-04 |
President And Fellows Of Harvard College |
Compositions for treating or preventing obesity and insulin resistance disorders
|
US20050142124A1
(en)
|
2003-12-31 |
2005-06-30 |
Kaiser Jon D. |
Nutrient compositions and methods for enhanced effectiveness of the immune system
|
AU2005211165B8
(en)
*
|
2004-01-28 |
2011-07-14 |
Nestec S.A. |
Nutritional composition for improving skin condition and preventing skin diseases
|
EP1577320B1
(en)
|
2004-03-19 |
2012-07-18 |
Institut Pasteur |
Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides
|
US20050232911A1
(en)
*
|
2004-04-19 |
2005-10-20 |
Schreiber Brian D |
Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
|
WO2006007411A2
(en)
*
|
2004-06-16 |
2006-01-19 |
President And Fellows Of Harvard College |
Methods and compositions for modulating bax-mediated apoptosis
|
US20070244202A1
(en)
*
|
2004-06-28 |
2007-10-18 |
Kao Corporation |
Ampk Activator
|
WO2006004722A2
(en)
*
|
2004-06-30 |
2006-01-12 |
Biomol Research Laboratories, Inc. |
Compositions and methods for selectively activating human sirtuins
|
ITRM20040395A1
(it)
*
|
2004-08-03 |
2004-11-03 |
Sigma Tau Ind Farmaceuti |
Composizione comprendente statine e acidi grassi omega 3.
|
US7709539B2
(en)
*
|
2004-08-11 |
2010-05-04 |
Chang Gung University |
Therapeutic use of resveratrol for hyperglycemia
|
CN104304671A
(zh)
|
2004-12-29 |
2015-01-28 |
希尔氏宠物营养品公司 |
抑制动物学习和/或记忆减退的方法
|
US8034450B2
(en)
*
|
2005-01-21 |
2011-10-11 |
Ocean Nutrition Canada Limited |
Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
|
CA2596023A1
(en)
*
|
2005-01-27 |
2006-11-09 |
Ocean Nutrition Canada Ltd. |
Fatty acid-benzenediol derivatives and methods of making and using thereof
|
WO2006109194A2
(en)
*
|
2005-01-27 |
2006-10-19 |
Ocean Nutrition Canada Ltd. |
Chromium-fatty acid compounds and methods of making and using thereof
|
CA2598792A1
(en)
*
|
2005-03-02 |
2006-09-08 |
Metanomics Gmbh |
Process for the production of fine chemicals
|
WO2006138418A2
(en)
|
2005-06-14 |
2006-12-28 |
President And Fellows Of Harvard College |
Improvement of cognitive performance with sirtuin activators
|
US20070149466A1
(en)
*
|
2005-07-07 |
2007-06-28 |
Michael Milburn |
Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
|
US9968120B2
(en)
*
|
2006-05-17 |
2018-05-15 |
Dsm Nutritional Products Ag |
Homogenized formulations containing microcapsules and methods of making and using thereof
|
US8722112B2
(en)
|
2005-07-14 |
2014-05-13 |
Hill's Pet Nutrition, Inc. |
Method for prolonging the life of animals
|
US8580750B2
(en)
|
2005-07-29 |
2013-11-12 |
Tima Foundation |
Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases
|
WO2007016949A1
(en)
*
|
2005-07-29 |
2007-02-15 |
Matuschka-Greiffenclau Markus |
Composition for reducing the risc of alcohol induced neuropathy
|
JP2007126390A
(ja)
*
|
2005-11-02 |
2007-05-24 |
Mercian Corp |
血糖値低下剤
|
GB0606864D0
(en)
*
|
2006-04-05 |
2006-05-17 |
Univ Nottingham |
Increades fatty acid oxidation
|
KR20090029699A
(ko)
*
|
2006-04-07 |
2009-03-23 |
오션 뉴트리션 캐나다 리미티드 |
낮은 계면장력 물질을 가지는 에멀젼 및 마이크로캡슐, 제조방법 및 이용방법
|
KR20170042364A
(ko)
*
|
2006-06-05 |
2017-04-18 |
디에스엠 뉴트리셔널 프라덕츠 아게 |
개선된 쉘을 가지는 마이크로캡슐
|
US10105405B2
(en)
|
2006-06-05 |
2018-10-23 |
Keyview Labs, Inc. |
Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A and ginkgo biloba
|
US8883814B2
(en)
|
2006-06-05 |
2014-11-11 |
Keyview Labs, Inc. |
Compositions and methods for enhancing brain function
|
US9308232B2
(en)
|
2006-06-05 |
2016-04-12 |
Keyview Labs, Inc. |
Compositions and methods for enhancing brain function
|
US10105406B2
(en)
|
2006-06-05 |
2018-10-23 |
Keyview Labs, Inc. |
Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A, Ginkgo biloba, and vitamin B complex
|
US20070281961A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Brite Age |
Modified Compositions And Methods For Enhancing Brain Function
|
US8071610B2
(en)
*
|
2006-06-05 |
2011-12-06 |
Josh Reynolds |
Compositions and methods for enhancing brain function
|
CA2675123C
(en)
|
2007-01-10 |
2017-04-11 |
Ocean Nutrition Canada Limited |
Vegetarian microcapsules
|
US20080226696A1
(en)
*
|
2007-03-15 |
2008-09-18 |
Ben Treadwell |
Methods of improving learning abilities of aged companion animals
|
PT2136798E
(pt)
*
|
2007-03-21 |
2015-10-15 |
Sigma Tau Ind Farmaceuti |
Composição útil para a prevenção da diabetes tipo 2 e sua complicações em pacientes pré-diabéticos com resistência à insulina
|
JP2010527952A
(ja)
*
|
2007-05-24 |
2010-08-19 |
シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ |
Ppar−ガンマアゴニストの使用に起因する有害作用の防止に有用な組成物
|
WO2010132502A2
(en)
|
2009-05-11 |
2010-11-18 |
Cytotech Labs, Llc |
Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
|
US20120053437A1
(en)
*
|
2010-08-25 |
2012-03-01 |
Hickle Randall S |
Monitored healthcare process for the treatment of specific health problems with medical foods and/or drugs
|
AU2012240222B2
(en)
|
2011-04-04 |
2017-04-27 |
Berg Llc |
Methods of treating central nervous system tumors
|
US9040082B2
(en)
|
2011-06-24 |
2015-05-26 |
K-Pax Pharmaceuticals, Inc. |
Compositions and methods for treatment of chronic fatigue
|
US8623924B2
(en)
|
2011-07-15 |
2014-01-07 |
Nusirt Sciences, Inc. |
Compositions and methods for modulating metabolic pathways
|
US9198454B2
(en)
|
2012-03-08 |
2015-12-01 |
Nusirt Sciences, Inc. |
Compositions, methods, and kits for regulating energy metabolism
|
AU2013344753B2
(en)
|
2012-11-13 |
2018-09-27 |
Nusirt Sciences, Inc. |
Compositions and methods for increasing energy metabolism
|
CA2902879C
(en)
|
2013-03-15 |
2023-09-26 |
Nusirt Sciences, Inc. |
Leucine and nicotinic acid reduces lipid levels
|
US10933032B2
(en)
|
2013-04-08 |
2021-03-02 |
Berg Llc |
Methods for the treatment of cancer using coenzyme Q10 combination therapies
|
EP3730131A1
(en)
|
2013-09-04 |
2020-10-28 |
Berg LLC |
Methods of treatment of cancer by continuous infusion of coenzyme q10
|
SG11201607075TA
(en)
|
2014-02-27 |
2016-09-29 |
Nusirt Sciences Inc |
Compositions and methods for the reduction or prevention of hepatic steatosis
|
WO2015166489A2
(en)
|
2014-04-28 |
2015-11-05 |
Yeda Research And Development Co. Ltd. |
Method and apparatus for predicting response to food
|
WO2016174677A1
(en)
*
|
2015-04-28 |
2016-11-03 |
Yeda Research And Development Co. Ltd. |
Use of microbial metabolites for treating diseases
|
CN108378355A
(zh)
*
|
2018-01-06 |
2018-08-10 |
福建古瑞森生物科技有限公司 |
降低2型糖尿病患者餐后血糖改善血脂增加肠道有益菌的餐前预营养组合物及其制备方法
|